Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

March 7, 2030

Study Completion Date

March 7, 2030

Conditions
Cardiac Sarcoidosis
Interventions
DIAGNOSTIC_TEST

PET/MRI

PET/MRI is a new-generation hybrid camera capable of simultaneously performing FDG positron emission tomography and gadolinium-injected MRI. PET/MRI could be a relevant prognostic marker of progression, and could significantly improve diagnostic performance in patients with suspected cardiac sarcoidosis.

Trial Locations (1)

Unknown

RECRUITING

Henri Mondor Hospital, Créteil

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER